Diseases · Entity Annotation Prototype (beta)

3articles mentioning diseases

3disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: secondary immunodeficiency ×

secondary immunodeficiency

This disease is selected. Its supporting articles are shown below.

secondary immunodeficiency3

Articles mentioning secondary immunodeficiency

3 articles · page 1 of 1

4CPS-264 Analysis and 10 year comparison of intravenous immunoglobulins utilisation in a tertiary hospital: evaluation of clinical appropriateness and economic impact

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

77.1%

myasthenia gravis multifocal motor neuropathy Chronic inflammatory demyelinating polyradiculoneuropathy common variable immunodeficiency CIDP secondary immunodeficiency haematological disorders IVIg tertiary hospital

…label. Evidence-supported off-label use represented 20.3%, with myasthenia gravis being the most common indication (13/153, 8.5%). While unsuppor…

PO:02:065 Human immunoglobulin therapy in a patient with systemic lupus erythematosus and active tuberculosis:case report

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

80.2%

Systemic Lupus Erythematosus Antiphospholipid syndrome Lupus nephritis Progressive SystemicSclerosis SLE secondary immunodeficiency Hydroxychloroquine Methylprednisolone Belimumab Azathioprine

…ases, IVIg is used off-label, but with great success. These are Systemic Lupus Erythematosus, Progressive SystemicSclerosis, Antiphospholipid syndrome, a nu…

Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) following first administration of immunoglobulin replacement

bmjcr · abstract · 2025-11-05 · 1 matching annotations

84.5%

multiple sclerosis SDRIFE secondary immunodeficiency Ig rituximab

…0s with secondary immunodeficiency from rituximab treatment for multiple sclerosis. 3 days after receiving her first dose of intravenous Ig, she d…